T
here have been many studies (1-5) of patients in whom treatment limitations were applied after a period of failed treatment and observation in the intensive care unit (ICU). Predictably, limitations of medical treatment, when applied to patients during their ICU stay, are highly predictive of death (6) . Over two thirds of these deaths occur in the ICU after a decision has been made to limit or withhold certain life-saving interventions (5, 7) . In addition, long-term survival for those who are discharged from the hospital alive may be very limited (5) . There are no studies, however, of patients in whom treatment limitation orders were in place at admission to ICU. Admission of these patients to ICU may appear somewhat contradictory, particularly if it is expected that a large proportion may eventually die. Thus, a better understanding of these patients and their epidemiology could assist clinicians in making more informed decisions regarding the usefulness and expected outcome of such ICU admissions.
The Australia and New Zealand Intensive Care Society Adult Patient Database (ANZICS APD) is a high-quality database that records demographic, severity of illness, and outcome data from adult ICU admissions, and it is one of the largest datasets of ICU admissions in the world (8) Background: Previous studies have addressed patients in whom treatment is withheld or withdrawn after a period of intensive care unit management. However, no studies have investigated the epidemiology of patients with treatment limitations in place at the time of intensive care unit admission.
Objective: To report the epidemiology and outcome of patients with treatment limitations at intensive care unit admission and to identify characteristics associated with survival and discharge to home.
Design: Retrospective database study using data from the Australian and New Zealand Intensive Care Society Adult Patient Database.
Setting: Australian and New Zealand intensive care units.
Patients:
One hundred eighty-seven thousand four hundred and one intensive care patients collected over a 3-yr period, 5,989 (3.2%) of whom had treatment limitations at admission to the intensive care unit.
Interventions: Retrospective database study with no interventions. Data collected included patient characteristics, length of stay, mortality, and discharge destination. Mean intensive care unit bed days were used as a surrogate for resource consumption.
Measurements Using the above database, we sought to describe the prevalence, demographics, outcomes, and resource use of patients with treatment limitations at admission to ICU, compare them to patients admitted for active management, and identify factors associated with survival to hospital discharge and factors associated with direct discharge to home. To provide supplementary detail about the type of treatment limited and the source of the limitation decision (none of which were available from the ANZICS database), we performed an additional case-note review of 100 patients at the hospital of the authors.
METHODS
The study was reviewed and approved by the Alfred Hospital Human Research Ethics Committee in April 2009.
Data Extracted. Access to the data was granted by the ANZICS Center for Outcome and Resource Evaluation Management Committee in accordance with standing protocols. All submissions to the ANZICS APD between January 1, 2007, (when treatment goal at admission was added as a variable), and December 31, 2009, were initially examined. Patients admitted to ICU for palliative care or organ donation were excluded, along with those who had no recorded treatment goals. ICU readmission episodes, patients with incomplete outcome data, and those who had a length of stay 365 days (assumed to be erroneous) were also excluded. Variables extracted included age, chronic health conditions, discharge location, and all variables required for calculation of the predicted risk of death from the Acute Physiology and Chronic Health Evaluation III-j (APACHE III-j) scoring system (9, 10). To provide additional information on patients who had no recorded treatment goals, we performed a separate analysis of those excluded patients.
The case-note analysis was carried out at the hospital of four of the main authors. One hundred sequential patients admitted to ICU over a period of 30 months with treatment limitations at admission were selected. Patients admitted for full active treatment, for palliative care, or for organ donation were not considered. Data collected included the patient's age, APACHE III score and risk of death, and mortality. Data specific to the treatments being limited were also collected. These included what treatments were limited at admission (i.e., cardiopulmonary resuscitation, defibrillation, intubation, dialysis, inotropes, blood, left ventricular assist device, or extracorporeal membrane oxygenation), who instigated the decision (i.e., doctor, patient, or family), and when and for what reason the decision was made. Each patient could have more than one answer and no variable was mutually exclusive.
Outcomes Measured. Outcomes considered were as follows:
1. Proportion of patients who survived to hospital discharge. 2. Proportion of patients who were discharged directly home. 3. ICU resource use.
In the absence of direct measures of ICU resource use, mean bed days in ICU were used as a surrogate measure. The number of bed days used per surviving patient was calculated to estimate "effective resource use."
Statistical Analysis. Normally distributed data were compared using Student's t tests and reported using means and standard deviations; nonparametric data were compared using Wilcoxon's rank sum tests and reported using medians and interquartile ranges. Chi-square tests were used to compare categorical data, with results reported as numbers (percentages). Multivariate models were constructed to determine factors independently associated with hospital survival and with discharge directly to home amongst patients with treatment limitations. The independent contributions of age, chronic health status, diagnosis, intubation, acute physiological status, and source of admission to ICU were assessed. Chronic comorbidities were examined as a continuous variable between 0 and 7 representing the number of comorbidities listed for each patient. The Acute Physiology Score component of the APACHE III-j score was calculated for each patient (i.e., the component without any contribution from age or chronic health variables) (11) . Only diagnoses with 50 patients were considered for entry into the model. To facilitate identification of specific diagnostic categories that may be predictive of survival, dummy variables were created for each primary diagnosis. A full list of variables entered into the model is provided in Appendix 1. Prediction models were developed using multiple logistic regression with stepwise selection and backwards elimination techniques. Models were constructed using all data from 2007 and 2008 and then validated on all data from 2009. Standard measures of discrimination (area under the receiver operator curve) and calibration (Hosmer-Lemeshow C statistic) were used to assess model performance. Statistical analyses were performed using SAS version 9. (Table 1) . Patients with treatment limitations were older, less likely to be admitted as a result of elective surgery, and more likely to be admitted from the emergency department or the ward. Such patients had a higher prevalence of acute renal failure, lower rate of intubation within the first 24 hrs of ICU admission, had higher severity of illness as measured by APACHE III-j, and were more likely to have chronic comorbid conditions and cancer. The ten most prevalent diagnoses in each group are displayed in Table 2 .
Outcomes. Table 3 shows the outcomes in each group. The mortality of patients with treatment limitations at admission to ICU was 53% (95% confidence interval 51.7%-54.3%), compared with 9% (95% confidence interval 8.9%-9.1%) for active management patients. After adjusting for severity of underlying illness using the APACHE III-j predicted risk of death, the presence of a treatment limitation was associated with nearly six-fold increase in risk of death (odds ratio 5.68, 95% confidence interval 5.32%-6.07%, p  .001).
Of the 2,836 patients in the treatment limitations group who survived to hospital discharge, nearly two thirds (1,784 patients) were discharged directly home. The remaining survivors were discharged to another hospital or to a chronic care facility; the ultimate number of these patients who were discharged home or who died was unknown.
Resource Use. There was similar resource consumption (as measured by ICU bed days) in the treatment limitations group compared to actively managed patients. Mean and median lengths of stay in the ICU and hospital were similar in both groups.
Of the patients in each group that died, actively managed patients used more ICU bed days (5.4 bed days) than those admitted with treatment limitations, whose bed day usage (2.3 days) was lower than survivors in both groups (3 bed days each).
Case-Note Analysis. Data from the casenote analysis of patients with treatment limitations at admission to ICU are displayed in Table 4 . The demographics of these patients were comparable to the demographics of the treatment limitations group in the main ANZICS APD data, with similar ages, APACHE III scores, APACHE III risk of death, and mortality (47% in case-note analysis, 53% in the ANZICS database). The origin of the treatment limitation was evident for 94 of the 100 patients. This revealed that 97% (n  91/94) originated from the doctor, 20% from the patient, and 27% from the family, and in some cases a combination of the three (Fig. 1) .
Multivariate Analysis. Amongst patients with treatment limitations at admission to ICU, factors associated with survival to hospital discharge and discharge directly home are shown in Tables  5 and 6 . A planned admission to ICU following elective surgery, younger age, smaller number of comorbidities, and lower acute physiology score were all associated with survival to hospital discharge and discharge directly home. Patients who had been admitted to ICU from another hospital were more likely to survive but unlikely to go directly home. Patients with diagnoses such as intracerebral and subarachnoid hemorrhage, stroke, cardiac arrest, cardiogenic shock, and aspiration pneumonia were likely to die and unlikely to be discharged home. Head injuries were very unlikely to be discharged home. In particular, admissions with intracranial or subarachnoid hemorrhage were associated with a negligible chance of discharge home. Diagnoses such as respiratory neoplasm, bacterial pneumonia, other respiratory disorders, nonurinary septic shock, and gastrointestinal perforation were also particularly unlikely to survive. Conversely, ICU admission diagnoses of postoperative gastrointestinal neoplasm, seizure, cholecystitis/cholangitis, and unspecified metabolic disorders were associated with an increased likelihood of survival. Renal disorders, chronic obstructive pulmonary disease, noncardiogenic pulmonary edema, and postoperative gastrointestinal bleeding were also associated with an increased likelihood of being discharged directly home.
DISCUSSION
Key Findings. We conducted a retrospective analysis of a large, international database to study the epidemiology of patients who had treatment limitations already in place at the time of ICU admission. We found that such patients comprised nearly 2,000 admissions per year in Australia and New Zealand. We also found that, despite such limitations, nearly half of these patients survived to hospital discharge and that one third were discharged directly to their homes. Supplementary data from 100 patient records provided specific information about the treatments limited at ICU admission, when the decision was made, by whom, and why. Finally, we found that several diagnostic, age-related, All p values . 001 for comparison between the two groups. This table shows the ten most prevalent admission diagnoses in each group. The number column signifies the number of admission for this diagnosis. The number shown in parentheses represents the percentage of patients for that diagnosis in that treatment group. comorbidity-related, and acute physiologyrelated variables were independently associated with different chances of survival or discharge home. In addition, resource consumption by these patients was similar to that of patients without treatment limitations. Patients excluded from the study due to no recorded treatment goals had similar characteristics to actively managed patients, suggesting that in many centers the default setting is to "do everything."
Relationship to Previous Studies. The outcomes of patients who have treatment limitations applied after ICU admission have been previously described (1) (2) (3) (4) (5) . Increasing age, comorbidities, and greater severity of illness have all been noted to be associated with a decision to limit treatment within ICU (5) and a reduced chance of survival (4), although the relationship of the admission diagnosis to eventual outcome (as described in our paper) has rarely been published. Withholding or limiting therapy during ICU admission (reported in 5% of ICU admissions submitted to the European Simplfied Acute Physiology Score 3 database) (12) is associated with mortality rates between 59% (4) and 86% (12), higher than the mortality seen in our study.
Our study is the first publication to examine the epidemiology of patients who have treatment limitations in place at admission to ICU. Such patients, although 3.2% of admissions, comprise nearly 2,000 patients per year in Australia and New Zealand, which if equated to an admission diagnosis would represent one of the top five most prevalent admitted to ICU. As such, a greater understanding of their characteristics and outcomes seems important.
Multivariate Modeling. The finding that younger patients, those with less comorbid diseases, lower levels of acute physiological disturbance, and those admitted following elective surgery were more likely to survive and be discharged home should not be surprising. However a number of admission diagnoses also appeared to have an important independent effect on a patient's likelihood of survival or discharge home. Neurological diagnoses such as intracerebral and sub arachnoid hemorrhage, stroke (and possibly head injury), along with diagnoses of cardiac arrest, and cardiogenic shock, and aspiration pneumonia were consistently associated with poor outcomes. A possible explanation for these findings includes the fact that the allocation of a treatment limitation order in these diagnostic groups carries with it a " self-fulfilling prophesy" effect, which influences the subsequent management of the patient. The probability that treatment limitations had such a causal effect on outcome may not be as likely in patients with a neurologic diagnosis, however, as these patients may be a subgroup in whom clinical experience recognized their probable poor outcome and implemented a treatment limitation order. It is important to note that none of these are patients who have been admitted for the purposes of palliative care (who were excluded from this study).
Conversely, renal disorders, noncardiogenic pulmonary edema, gastrointestinal bleeding, and chronic obstructive pulmonary disease (the latter being the most prevalent diagnosis amongst the treatment limitations group) were associated with good outcomes and discharge directly home. Whether this represents an incorrect level of prognostic pessimism in these patients or whether treatment limitations were inappropriately applied cannot be determined from this study. A possible explanation of the good outcomes in some of these subsets may be that patients self-elected treatment limitations due to poor baseline quality of life when their clinicians would not otherwise have done so. This may have meant they were not as physiologically unwell as patients who have treatment limitation orders, thus demonstrating a relative improvement in outcome. The fact that the ANZICS APD does not record the originator of treatment limitation decision makes it impossible to know what degree the effect of this scenario may have had on these results. However, the case-note analysis revealed that of the 20 patients for whom there was documentation that the patient requested limitation of treatment, only one of these 20 patients (5%) had one of the above diagnoses associated with a good outcome.
The multivariate model for survival had better discrimination and calibration than that developed for discharge to home. The conclusions drawn from the latter model should be considered provisional until further research is performed.
Resource Use. Specific assessments of resource use such as the Therapeutic Intervention Scoring System (13, 14) and the Nine Equivalents of Nursing Manpower Score (15) were not available to the investigators, but since there is a strong correlation between length of stay, resource use, and cost (16) , ICU bed day usage was considered an appropriate surrogate measure. We could find no evidence that patients with treatment limitations at admission to ICU consumed more resources than those admitted for active management. If anything the converse was true, with those that died in ICU consuming the smallest number of ICU bed days per patient. Consideration of the appropriateness of allocation of resources to this patient group is outside of the scope of this study.
Case-Note Analysis. The similar demographic and outcome data of the case-note analysis patients to the treatment limitations group in the main ANZICS APD data suggests that the patients examined in the case-note analysis may be representative of practice throughout Australia and New Zealand. It is recognized, however, that this is data from a single institution where practices may differ from other hospitals and where therapies are available that are not provided at other hospitals in Australia and New Zealand, such as extracorporeal membrane oxygenation and left ventricular assist devices.
Limitations. This was a retrospective registry-based study and is therefore affected by all the limitations inherent to such studies. Despite the ANZICS APD being considered a high-quality database (8) , the extent and impact of data inaccuracies and unmeasured confounders on the findings cannot fully be known. Although the majority of ICUs and ICU admissions in Australia are represented in the APD, the applicability of Associations have been reported on data from the whole cohort, n  5989. our findings to units that do not submit data (mostly rural and private ICUs) is unknown. The ultimate destination of patients discharged to other hospitals or chronic care facilities and the long-term outcomes of survivors were unknown. Any changes in a patient's treatment goals following admission to ICU were not recorded. The use of mean bed days as a measure of resource use may be limited in direct comparison of the two main groups, as patients admitted to ICU with treatment limitations may not have used as many resources (renal replacement, invasive ventilation, etc.) as actively managed patients would do in the same length of stay. In addition, it is unknown to what degree the outcomes seen were directly affected by processes of care within the ICU, such as organizational structure (which is known to influence outcomes) (17) or by the contribution of characteristics such as functional status and quality of life projections. It is unknown to what degree the results of the case-note analysis are representative of practices throughout Australia and New Zealand.
Despite the stated limitations, our findings may assist clinical decision-making concerning the admission of patients with treatment limitations to ICU. They should improve appropriate counseling of family members, and may allow informed consideration of resource allocation in the knowledge that varying diagnostic groups may have very different expected outcomes.
CONCLUSIONS
This is a comprehensive examination of a group of ICU patients who have not been previously investigated. Patients with treatment limitations at ICU admission comprised a significant number (approximately 2,000 per year) throughout Australia and New Zealand in whom it was possible to determine factors associated with outcome. Our findings indicate that such patients had a surprisingly high rate of hospital survival and discharge home. In addition, these patients did not consume a disproportionately large amount of resources and displayed features at admission that may assist in identifying risk of death. More studies are required to confirm our findings in other geographical settings, to investigate cost-effectiveness of ICU admission in these patients, and to further investigate the types of treatments limited and therapies received. Associations have been reported on data from the whole cohort, n  5989.
